Skip to main content
IONS logo

IONS · Ionis Pharmaceuticals Inc

Track IONS — free
$57.24 +1.37 (+2.45%) At close · Aug 14
Market Cap
$9.51B
Shares
166.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024
Executive Total
Mariana Baroldi $679,035
Fiscal 2023
Executive Total
Mariana Baroldi $513,949
Fiscal 2022
Executive Total
Mariana Baroldi $370,238
Grant Swayze $68,951
Fiscal 2021
Executive Total
Elizabeth Hougen $4,128,329
Patrick R. O’Neil $3,923,145
Onaiza Cadoret-Manier $3,665,966
Eric Swayze $3,619,450
Fiscal 2020
Executive Total
Elizabeth Hougen $4,341,100
Patrick R. O’Neil $3,965,065
Onaiza Cadoret-Manier $3,504,442
Eric Swayze $2,342,700
Fiscal 2019
Executive Total
Brett Monia $6,527,963
Elizabeth Hougen $3,481,858
Patrick R. O’Neil $3,463,901
Eric Swayze $2,112,032

Executive changes

Person Change Filed
Peter N. Reikes Appointed 2026-06-08
Ludwig N. Hantson Appointed 2026-06-08
Peter N. Reikes Appointed 2026-03-09
Holly Kordasiewicz, Ph.D. Appointed 2025-06-12
Richard Geary, Ph.D. Retired 2025-06-12
Kyle Jenné Appointed 2024-02-29
Michael Yang Appointed 2023-12-14
Frederick Muto Retired 2022-07-18
Key facts CIK 874015 CUSIP 462222100 13F (30d) 498 filings 470 filers Visit website Investor relations